| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms D Malkin, FP Li, LC Strong, JF Fraumeni, CE Nelson, DH Kim, J Kassel, ... Science 250 (4985), 1233-1238, 1990 | 4040 | 1990 |
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 KM Dameron, OV Volpert, MA Tainsky, N Bouck Science 265 (5178), 1582-1584, 1994 | 1772 | 1994 |
| Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Y Yin, MA Tainsky, FZ Bischoff, LC Strong, GM Wahl Cell 70 (6), 937-948, 1992 | 1261 | 1992 |
| Molecular cloning of a new transforming gene from a chemically transformed human cell line CS Cooper, M Park, DG Blair, MA Tainsky, K Huebner, CM Croce, ... Nature 311 (5981), 29, 1984 | 1011 | 1984 |
| In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. M Harvey, AT Sands, RS Weiss, ME Hegi, RW Wiseman, P Pantazis, ... Oncogene 8 (9), 2457-2467, 1993 | 560 | 1993 |
| Programming gene expression in developing epidermis C Byrne, M Tainsky, E Fuchs Development 120 (9), 2369-2383, 1994 | 532 | 1994 |
| Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle SC Dryden, FA Nahhas, JE Nowak, AS Goustin, MA Tainsky Molecular and cellular biology 23 (9), 3173-3185, 2003 | 475 | 2003 |
| Onto-tools, the toolkit of the modern biologist: onto-express, onto-compare, onto-design and onto-translate S Draghici, P Khatri, P Bhavsar, A Shah, SA Krawetz, MA Tainsky Nucleic acids research 31 (13), 3775-3781, 2003 | 409 | 2003 |
| Ras gene mutation and amplification in human nonmelanoma skin cancers WE Pierceall, LH Goldberg, MA Tainsky, T Mukhopadhyay, ... Molecular carcinogenesis 4 (3), 196-202, 1991 | 308 | 1991 |
| Loss of AP‐2 results in downregulation of c‐KIT and enhancement of melanoma tumorigenicity and metastasis S Huang, D Jean, M Luca, MA Tainsky, M Bar‐Eli The EMBO journal 17 (15), 4358-4369, 1998 | 286 | 1998 |
| Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization FZ Bischoff, SO Yim, S Pathak, G Grant, MJ Siciliano, BC Giovanella, ... Cancer research 50 (24), 7979-7984, 1990 | 276 | 1990 |
| Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA T Mukhopadhyay, M Tainsky, AC Cavender, JA Roth Cancer Research 51 (6), 1744-1748, 1991 | 253 | 1991 |
| Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays M Chatterjee, S Mohapatra, A Ionan, G Bawa, R Ali-Fehmi, X Wang, ... Cancer research 66 (2), 1181-1190, 2006 | 233 | 2006 |
| The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. EN Olson, G Spizz, MA Tainsky Molecular and Cellular Biology 7 (6), 2104-2111, 1987 | 208 | 1987 |
| Loss of AP-2 results in up-regulation ofMCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells D Jean, JE Gershenwald, S Huang, M Luca, MJ Hudson, MA Tainsky, ... Journal of Biological Chemistry 273 (26), 16501-16508, 1998 | 192 | 1998 |
| Critical pathways in cellular senescence and immortalization revealed by gene expression profiling AL Fridman, MA Tainsky Oncogene 27 (46), 5975, 2008 | 183 | 2008 |
| Defective G2 checkpoint function in cells from individuals with familial cancer syndromes RS Paules, EN Levedakou, SJ Wilson, CL Innes, N Rhodes, TD Tlsty, ... Cancer research 55 (8), 1763-1773, 1995 | 179 | 1995 |
| Breast cancer genetics in African Americans OI Olopade, JD Fackenthal, G Dunston, MA Tainsky, F Collins, ... Cancer 97 (S1), 236-245, 2003 | 170 | 2003 |
| Stochastic cancer progression driven by non‐clonal chromosome aberrations HHQ Heng, JB Stevens, G Liu, SW Bremer, KJ Ye, PV Reddy, GS Wu, ... Journal of cellular physiology 208 (2), 461-472, 2006 | 161 | 2006 |
| PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation P Kannan, Y Yu, S Wankhade, MA Tainsky Nucleic acids research 27 (3), 866-874, 1999 | 159 | 1999 |
